Literature DB >> 19473053

Analysis of VEGF, Flt-1, Flk-1, nestin and MMP-9 in relation to astrocytoma pathogenesis and progression.

A Hlobilkova1, J Ehrmann, P Knizetova, V Krejci, O Kalita, Z Kolar.   

Abstract

Astrocytomas, particularly high grade astrocytoma, are brain tumors with potent angiogenic activity. Our immnunohistochemical study assessed vascular endothelial growth factor (VEGF), VEGF receptors (Flk-1, and Flt-1), the intermediate filamental protein nestin which plays a role in central nervous system development, and MMP-9, which belongs the family of matrix metalloproteinases implicated in tumor invasion and angiogenesis regulation. We investigated the expression of VEGF, its receptors, nestin and MMP-9 in astrocytomas and their correlation with tumor grade. We used paraffin-embedded samples from 66 patients, 29 with low grade (WHO-grade II) and 37 with high grade (WHO-grade III and IV) astrocytomas. Antibodies against VEGF, Flk-1, Flt1, nestin, CD34 and MMP-9 were used, followed by standard indirect immunohistochemical methods. Expression of Flt-1 and Flk-1 showed no significant differences between low and high grade tumor groups. Expression of VEGF and MMP-9 was increased in the high grade group (p equal to or less than 0.026 and 0.024). Nestin expression in tumor astrocytes and endothelial cells increased in high grade group (p same 0.007 and 0.003). Higher expression of VEGF in high grade astrocytomas may subsequently lead to activation of survival, angiogenesis and migration. Expression of nestin and MMP-9 also suggest their likely role in astrocytoma vascular development and proliferation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19473053     DOI: 10.4149/neo_2009_04_284

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  19 in total

1.  Capturing changes in the brain microenvironment during initial steps of breast cancer brain metastasis.

Authors:  Mihaela Lorger; Brunhilde Felding-Habermann
Journal:  Am J Pathol       Date:  2010-04-09       Impact factor: 4.307

Review 2.  Review on intermediate filaments of the nervous system and their pathological alterations.

Authors:  Claire Lépinoux-Chambaud; Joël Eyer
Journal:  Histochem Cell Biol       Date:  2013-06-08       Impact factor: 4.304

3.  Imaging the impact of Nox4 in cycling hypoxia-mediated U87 glioblastoma invasion and infiltration.

Authors:  Chia-Hung Hsieh; Hao-Teng Chang; Wu-Chung Shen; Woei-Cherng Shyu; Ren-Shyan Liu
Journal:  Mol Imaging Biol       Date:  2012-08       Impact factor: 3.488

4.  Therapeutic effects of the Sp1 inhibitor mithramycin A in glioblastoma.

Authors:  Janina Seznec; Björn Silkenstedt; Ulrike Naumann
Journal:  J Neurooncol       Date:  2010-06-17       Impact factor: 4.130

Review 5.  Nestin: a novel angiogenesis marker and possible target for tumor angiogenesis.

Authors:  Yoko Matsuda; Masahito Hagio; Toshiyuki Ishiwata
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

Review 6.  Anti-tumor activities of matrine and oxymatrine: literature review.

Authors:  Yan Liu; Yang Xu; Weidan Ji; Xiaoya Li; Bin Sun; Quangen Gao; Changqing Su
Journal:  Tumour Biol       Date:  2014-02-14

7.  Lupeol induces apoptosis and inhibits invasion in gallbladder carcinoma GBC-SD cells by suppression of EGFR/MMP-9 signaling pathway.

Authors:  Yan Liu; Tingting Bi; Genhai Shen; Zhimin Li; Guoliang Wu; Zheng Wang; Liqiang Qian; Quangen Gao
Journal:  Cytotechnology       Date:  2014-07-19       Impact factor: 2.058

8.  Overexpression of vascular endothelial growth factor indicates poor outcomes of glioma: a systematic review and meta-analysis.

Authors:  Wenjie Chen; Deshen He; Zuyun Li; Xin Zhang; Denghua Pan; Gang Chen
Journal:  Int J Clin Exp Med       Date:  2015-06-15

Review 9.  VEGF targets the tumour cell.

Authors:  Hira Lal Goel; Arthur M Mercurio
Journal:  Nat Rev Cancer       Date:  2013-12       Impact factor: 60.716

10.  Knockdown of Nestin inhibits proliferation and migration of colorectal cancer cells.

Authors:  Jing Li; Rui Wang; Lei Yang; Qi Wu; Qinwan Wang; Zhengchao Nie; Yongchun Yu; Ji Ma; Qiuhui Pan
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.